CVE-2026-101451

Analyzed Analyzed - Analysis Complete

Stored Cross-Site Scripting in Oracle Siebel Life Sciences

Publication date: 2026-10-20

Last updated on: 2026-11-09

Assigner: Oracle

Description

Vulnerability in the Siebel Life Sciences product of Oracle Siebel CRM (component: Web UI). Supported versions that are affected are 17.0-26.9. Easily exploitable vulnerability allows low privileged attacker with network access via HTTP to compromise Siebel Life Sciences. Successful attacks require human interaction from a person other than the attacker and while the vulnerability is in Siebel Life Sciences, attacks may significantly impact additional products (scope change). Successful attacks of this vulnerability can result in unauthorized creation, deletion or modification access to critical data or all Siebel Life Sciences accessible data as well as unauthorized access to critical data or complete access to all Siebel Life Sciences accessible data. CVSS 3.1 Base Score 8.7 (Confidentiality and Integrity impacts). CVSS Vector: (CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:H/I:H/A:N).

CVSS Scores

EPSS Scores

Probability:
Percentile:

Meta Information

Published

2026-10-20

Last Modified

2026-11-09

Generated

2026-11-10

AI Q&A

2026-10-21

EPSS Evaluated

2026-11-08

NVD

CVE-2026-101451

EUVD

EUVD-2026-105867

Affected Vendors & Products

Vendor	Product	Version / Range
oracle	siebel_crm	From 17.0 (inc) to 26.9 (inc)

Helpful Resources

Exploitability

CWE

KEV

CWE ID	Description
CWE-352	The web application does not, or cannot, sufficiently verify whether a request was intentionally provided by the user who sent the request, which could have originated from an unauthorized actor.
CWE-284	The product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.

Attack-Flow Graph

Executive Summary

This is a vulnerability in Oracle Siebel CRM's Siebel Life Sciences product affecting versions 17.0-26.9. It allows a low-privileged attacker with network access via HTTP to potentially compromise the system. Exploitation requires human interaction beyond the attacker and may impact other products.

Detection Guidance

This vulnerability affects Oracle Siebel Life Sciences versions 17.0-26.9 and requires network access via HTTP. Detection should focus on identifying vulnerable versions of Siebel Life Sciences and monitoring for unauthorized data access or modifications. Check Oracle's official advisories for patches and review HTTP traffic logs for suspicious activity targeting the Web UI component.

Impact Analysis

An attacker could exploit this to create, delete, or modify critical data in Siebel Life Sciences. They could also gain unauthorized access to sensitive data, potentially affecting confidentiality and integrity of stored information.

Compliance Impact

This vulnerability could lead to unauthorized data access or modification, which may violate GDPR (data protection) or HIPAA (health data privacy) requirements. Non-compliance risks include legal penalties and reputational damage.

Mitigation Strategies

Apply the latest Oracle Critical Patch Update (CPU) for Siebel Life Sciences versions 17.0-26.9. Monitor Oracle's security advisories for updates. Restrict network access to the Siebel Life Sciences component via HTTP. Implement strong authentication and authorization controls for users with low privileges.

Hi! I’m here to help you understand CVE-2026-101451. Ask me anything about the vulnerability, its impact, or mitigation strategies.

0/70

EPSS Chart

Security Radar

News mentioning this vulnerability

Loading related security news...